- Investing Ideas
- /
- Pharmaceuticals & Biotech Consumer Discretionary
Pharmaceuticals & Biotech Consumer Discretionary
Results
1272
0 new
All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.
1,272 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
APLT | US$8.27 | 7.4% | 232.1% | US$949.8m | US$12.50 | PB13.1x | E54.7% | n/a | ||
AMYT | US$14.70 | 0.7% | 86.5% | US$940.7m | US$20.75 | PS3.9x | E53.9% | n/a | ||
PAHC | US$22.07 | -0.9% | 72.8% | US$893.9m | US$15.60 | PE370x | E51.5% | 2.2% | ||
ZYME | US$12.42 | -5.1% | 95.9% | US$882.4m | US$13.90 | PS14.1x | E-6.0% | n/a | ||
IMNM | US$14.38 | -4.1% | 72.2% | US$863.6m | US$30.60 | PS80.1x | E14.0% | n/a | ||
MDXG | US$5.83 | -4.9% | -20.0% | US$855.9m | US$12.20 | PE10.9x | E-7.0% | n/a | ||
SLN | US$18.25 | -0.1% | 85.8% | US$854.1m | US$57.20 | PS35.7x | E-11.9% | n/a | ||
CATX | US$12.57 | -5.0% | 359.3% | US$847.6m | US$22.31 | PS578.9x | E9.1% | n/a | ||
LQDA | US$10.01 | 0.6% | 57.9% | US$844.6m | US$24.00 | PS56.9x | E52.5% | n/a | ||
TNGX | US$7.47 | -10.0% | -33.7% | US$800.4m | US$16.13 | PS18.8x | E-3.9% | n/a | ||
NUVB | US$2.39 | -14.6% | 78.4% | US$800.1m | US$6.75 | PS557.6x | E41.2% | n/a | ||
CRGX | US$17.42 | -27.0% | n/a | US$799.7m | US$31.50 | PB1.8x | E1.7% | n/a | ||
DNTH | US$27.24 | -2.7% | 99.3% | US$799.6m | US$50.33 | PS194.2x | E-19.2% | n/a | ||
MBX | US$23.95 | 6.2% | n/a | US$799.5m | n/a | PE-16.9x | n/a | n/a | ||
ORKA | US$22.83 | -8.7% | n/a | US$799.0m | US$41.25 | n/a | n/a | n/a | ||
ICPT | US$19.00 | 0.1% | 19.1% | US$794.7m | US$19.00 | PS2.5x | E42.4% | n/a | ||
RAPP | US$21.33 | 0.5% | n/a | US$780.2m | US$35.00 | PB2.3x | E-31.8% | n/a | ||
ICVX | US$15.31 | -0.6% | 68.8% | US$777.8m | US$17.91 | PB3.3x | E20.9% | n/a | ||
AVBP | US$23.00 | -7.3% | n/a | US$772.5m | US$38.00 | PB2.6x | E14.3% | n/a | ||
ABCL | US$2.61 | 0.8% | -43.3% | US$769.1m | US$14.00 | PS23.3x | E-13.1% | n/a | ||
ETNB | US$7.26 | -11.4% | -53.0% | US$768.4m | US$30.63 | PB1.5x | E18.3% | n/a | ||
REPL | US$11.16 | 2.3% | -34.8% | US$762.5m | US$15.67 | PB1.8x | E22.2% | n/a | ||
ERAS | US$2.68 | -7.3% | 36.0% | US$756.8m | US$5.38 | PB1.7x | E-6.1% | n/a | ||
ORIC | US$10.65 | -5.3% | 76.0% | US$751.3m | US$18.78 | PB2.5x | E-5.9% | n/a |